Tilman Sauerbruch is an expert in Gastroenterology at University Hospital Bonn (Germany). As of October 2026, ScienceLeadR ranks Tilman Sauerbruch in the top 1% of experts worldwide for Gastrointestinal Hemorrhage, Liver Cirrhosis and Biliary Tract Diseases. Tilman Sauerbruch has authored 991 publications, the most recent in 2026, and is an investigator in 3 clinical trials. SLR score: 3,026 (community average: 125). How the SLR is computed.

LeadR Profile

Tilman Sauerbruch University Hospital Bonn Germany
3 026 ScienceLeadR Reputation 3026
Network Map

Gastroenterology

Subspecialties: Hepatology - Pharmacy - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1987 - 2026

Source: PubMed

University Hospital Bonn

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Short-term mortality is reduced and low grade ACLF reversed by TIPS in patients with fluid overload: a case-control study.
PMID 42407083 — hypertension, mortality, acute-on-chronic liver failure, portasystemic shunt, transjugular intrahepatic, gastroenterology, case-control studies, hepatorenal syndrome, liver
Clin Transl Gastroenterol20260
The non-surgical therapy of uncomplicated gallbladder stones: is there a niche?
PMID 41983901 — gallstones, ursodeoxycholic acid, gallbladder, cholesterol, cholecystectomy, risk factors, research, therapeutics
Expert Rev Gastroenterol Hepatol20260
Prävention und Vorsorge.
PMID 41945093 — internal medicine
Inn Med (Heidelb)20260
Recommendations on Drug Selection and Dose Adjustment for Patients with Liver Cirrhosis: Results from a Multidisciplinary Expert Panel.
PMID 41806204 — liver cirrhosis, pharmaceutical preparations, drug therapy, liver, gastroenterologists
Clin Drug Investig20260
[Rare diseases: the role of internal medicine].
PMID 40272470 — rare diseases, pharmaceutical preparations, internal medicine
Inn Med (Heidelb)20250

Clinical Studies 3

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 2
N/A 1

By status:

Completed 3

By type:

Interventional 3

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 3

Main Topics

Cohort/Consortium Investigators 3

LeadR Networks

Main global connection map